GIDARI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 950
AS - Asia 750
EU - Europa 605
SA - Sud America 131
AF - Africa 18
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.458
Nazione #
US - Stati Uniti d'America 920
SG - Singapore 403
IT - Italia 214
BR - Brasile 104
HK - Hong Kong 99
IE - Irlanda 91
CN - Cina 82
RU - Federazione Russa 67
DE - Germania 61
FR - Francia 46
VN - Vietnam 46
KR - Corea 37
FI - Finlandia 29
GB - Regno Unito 26
IN - India 18
CA - Canada 16
AT - Austria 13
MX - Messico 9
AR - Argentina 8
BD - Bangladesh 8
JP - Giappone 8
NL - Olanda 8
PL - Polonia 8
UA - Ucraina 8
ID - Indonesia 7
CO - Colombia 6
IQ - Iraq 6
LT - Lituania 6
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CZ - Repubblica Ceca 4
ES - Italia 4
MA - Marocco 4
MY - Malesia 4
PK - Pakistan 4
SE - Svezia 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
CH - Svizzera 3
EC - Ecuador 3
TR - Turchia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AU - Australia 2
LY - Libia 2
MD - Moldavia 2
PE - Perù 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MR - Mauritania 1
MT - Malta 1
OM - Oman 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
WS - Samoa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.458
Città #
Singapore 312
San Jose 125
Perugia 113
Chandler 99
Hong Kong 99
Ashburn 98
Dublin 91
Boardman 39
Seoul 36
Santa Clara 35
Los Angeles 34
Munich 34
Lauterbourg 27
Moscow 27
New York 26
Columbus 22
San Mateo 20
Ho Chi Minh City 19
Redmond 19
Turku 18
Wilmington 17
The Dalles 16
Piscataway 15
Altamura 13
Medford 12
Princeton 12
Hanoi 11
Lawrence 11
São Paulo 11
Dallas 10
Poplar 10
Florence 9
Milan 9
Ann Arbor 8
Bastia umbra 8
Beijing 8
Bologna 8
Montreal 8
Nuremberg 8
Rome 8
Tokyo 8
Warsaw 8
Helsinki 7
Brooklyn 6
Chennai 6
Council Bluffs 6
Frankfurt am Main 6
Orem 6
Paris 6
Toronto 6
Vienna 6
Baghdad 5
Falkenstein 5
Hefei 5
Mexico City 5
Mumbai 5
Padova 5
Andover 4
Boston 4
Brussels 4
Denver 4
Des Moines 4
Dhaka 4
Lappeenranta 4
Medellín 4
Atlanta 3
Belo Horizonte 3
Den Haag 3
Houston 3
London 3
Manchester 3
Phoenix 3
Querétaro 3
Rio de Janeiro 3
Seattle 3
Stockholm 3
Tappahannock 3
Amsterdam 2
Ankara 2
Baku 2
Chengdu 2
Chicago 2
Chisinau 2
City of London 2
Da Nang 2
Dubai 2
Duque de Caxias 2
Falls Church 2
Guangzhou 2
Juiz de Fora 2
Kyiv 2
Maceió 2
Madrid 2
Manaus 2
Naples 2
Oklahoma City 2
Olomouc 2
Piracicaba 2
Porto Alegre 2
Recife 2
Totale 1.720
Nome #
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 145
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 140
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 120
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 118
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 111
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 110
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 109
Low brachial artery flow-mediated dilation predicts worse prognosis in hospitalized patients with covid-19 100
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 99
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 96
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 95
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 95
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO) 94
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 84
BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV 84
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 83
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 80
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir 79
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 75
Nelfinavir: An Old Ally in the COVID-19 Fight? 74
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? 73
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 67
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report 65
Chronic antibiotic suppressive therapy with dalbavancin: a case series 64
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV 64
Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm 61
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication 60
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV 45
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study 42
Pseudomonas aeruginosa Isolation from Urine Culture in Hospitalised Patients: Incidence of Complicated Urinary Tract Infections and Asymptomatic Bacteriurias and Impact on Treatment of the EUCAST 2020 Update 17
Totale 2.549
Categoria #
all - tutte 11.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 0 0 0 19 1 17
2021/2022108 6 19 3 2 4 5 1 17 7 6 24 14
2022/2023328 12 45 5 49 29 26 3 15 122 0 17 5
2023/2024184 7 21 5 2 4 4 57 1 12 11 30 30
2024/2025664 15 42 19 32 35 46 92 65 102 58 97 61
2025/20261.194 71 89 63 199 186 98 221 55 118 94 0 0
Totale 2.549